Showing results (291-300 of 307) with videos related to
Sort By:
Pageof 31
Journal of the Neurological Sciences|October 5, 2024
A contemporary evaluation of the frequency & factors associated with overt stroke across the lifespan: A Ghanaian sickle cell disease registry analysisFred Stephen Sarfo, Vivian Paintsil, Isaac Nyanor, et al.Emerging Infectious Diseases|December 27, 2022
Efficiency of Field Laboratories for Ebola Virus Disease Outbreak during Chronic Insecurity, Eastern Democratic Republic of the Congo, 2018-2020Daniel Mukadi-Bamuleka, Fabrice Mambu-Mbika, Anja De Weggheleire, et al.The Lancet. Global Health|September 20, 2025
Sustained efficacy of the RTS,S/AS01<sub>E</sub> malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trialLawrence Osei-Tutu, Simon K Kariuki, Cynthia K Lee, et al.Journal of the American Academy of Dermatology|February 10, 2024
Treatment for central centrifugal cicatricial alopecia-Delphi consensus recommendationsTiaranesha Jackson, Yacine Sow, Jewell Dinkins, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2020
The cost of insecurity: from flare-up to control of a major Ebola virus disease hotspot during the outbreak in the Democratic Republic of the Congo, 2019Thibaut Jombart, Christopher I Jarvis, Samuel Mesfin, et al.MMWR. Morbidity and Mortality Weekly Report|December 20, 2019
Ebola Virus Disease Outbreak - Democratic Republic of the Congo, August 2018-November 2019Aaron Aruna, Placide Mbala, Luigi Minikulu, et al.Pathogens (Basel, Switzerland)|March 27, 2024
Lower Limb Paralysis Associated with Chikungunya in Kinshasa, the Democratic Republic of the Congo: Survey ReportMathy Matungala-Pafubel, Junior Bulabula-Penge, Meris Matondo-Kuamfumu, et al.The Journal of Infectious Diseases|March 4, 2024
Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria VaccineNelli Westercamp, Lawrence Osei-Tutu, Lode Schuerman, et al.The Lancet. Infectious Diseases|June 26, 2022
Efficacy of RTS,S/AS01<sub>E</sub> malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trialAaron M Samuels, Daniel Ansong, Simon K Kariuki, et al.The American Journal of Tropical Medicine and Hygiene|July 30, 2014
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoitesSeif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, et al.Pageof 31